Efficacy of Empagliflozin and Pioglitazone in Diabetic Patients With NAFLD

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This clinical trial will yield results about the therapeutic effect of combining pioglitazone with SGLT2i in people suffering from NAFLD associated with T2DM. Study participants will be asked to fill out a few questions on proforma that will obtain demographic information as well as information relating to their health. In addition, some blood tests will be done following standard procedures.
Epistemonikos ID: 6694541d9cb1b0128d59a76ec96a95d0998221ed
First added on: May 15, 2024